LSTA1 (certepetide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LSTA1 (certepetide), covering 2024-10-22 to 2024-10-22. Get the full timeline:
Most recent: Clinical Trial Update: The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]